What You Should Know:
- Vida Health is expanding its solution for chronic conditions by adding the ability to prescribe and deprescribe glucagon-like peptide 1 (GLP-1) agonists for both type 2 diabetes and obesity for appropriate patients. As part of Vida’s value-oriented treatments for cardiometabolic conditions, patients with obesity and diabetes will now be candidates for GLP-1 therapy within the Vida platform.
- With the addition of GLP-1s and other obesity medications in higher acuity
Read More
Diabetes| Type 1 & 2 Diabetes Management | Policy, News, Analysis, Insights - HIT Consultant
Veradigm and HealthVerity Partner to Advance Real-World Evidence for Cardiovascular Disease and Diabetes
What You Should Know:
- Today, Veradigm and HealthVerity announced a collaboration to advance research and improve patient care for those with cardiovascular disease and diabetes. The collaboration makes Veradigm’s data from their Cardiovascular and Metabolic Registries fully interoperable with de-identified patient data from HealthVerity Marketplace, the nation’s largest healthcare and consumer data ecosystem.
- The HealthVerity IPGE platform is an integrated technology and
Read More
DarioHealth Integrates Dexcom CGM Data into Diabetes Platform
What You Should Know:
- DarioHealth announced a partnership with Dexcom, the global leader in real-time continuous glucose monitoring (CGM) technology, to integrate its market-leading CGM data into Dario's multi-chronic condition platform.
- Dexcom CGM uses a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health. This agreement enables the integration
Read More
Blood Sugar Monitoring Devices Pose Wearability & Use Problems for Older Diabetic Adults & Caregivers
What You Should Know:
- In an initial trial of continuous glucometer use, faulty device adhesive -- a serious wearability challenge -- and patient difficulty in interpreting graphs produced by the device, were noted. In a subsequent trial, 70 older adults with diabetes wore glucometers and activity monitors and used smartphones and electronic medication bottles to track and manage blood sugar over a two-week period.
- Among these 70 patients, two-thirds of whom were African American and
Read More
Blue Shield of California, Virta Health Partners to Reverse Type 2 Diabetes in California
What You Should Know:
- Blue Shield of California has expanded its partnership with Virta Health to help reverse the human and financial impact of type 2 diabetes in the state.
- The partnership marks Blue Shield as the first health plan in California to implement a digital diabetes reversal solution across multiple lines of business.
Blue Shield is first health plan in California to implement digital diabetes reversal solution across multiple lines of business.
As part of Blue
Read More
6 Healthcare Trends Impacting Medical Practices in 2023
What You Should Know:
- AdvancedMD, a provider of cloud healthcare software for independent medical, mental health, and physical therapy practices, announced today the top six healthcare trends that will have the biggest impact on physicians and medical offices in 2023.
- These trends are based on aggregated, anonymous user data from the more than 40,000 practitioners spanning 13,000 medical practices that subscribe to AdvancedMD practice management, EHR and patient engagement
Read More
Simple HealthKit Raises $8M to Transform Health Diagnostics and Follow-Up Care
What You Should Know:
- Simple HealthKit raises $8M in Series A funding led by Initialized Capital to address health inequity with the first human-centric, end-to-end healthcare platform that builds and delivers diagnostics, treatment and follow-up care for all
- The Series A round also included participation from seed investors Kleiner Perkins, Kapor Capital and Quest Venture Partners, bringing Simple HealthKit’s total funding to date to $12M.
End-to-End Diagnostics and Digital Health
Read More
Hurdle Launches At-Home HbA1c Diagnostic Test to Tackle Diabetes Crisis
What You Should Know:
- Hurdle, a diagnostics-as-a-service company launches an at-home Hemoglobin A1c (HbA1c) Test that enables adult consumers to take a simple at-home blood sample to screen and monitor for diabetes.
- Developed by leading scientists, Hurdle’s testing technology offers leading accuracy and reliability and operates in partnership with labs that hold themselves to the highest testing standards. The test is available for purchase today on the Chronomics brand online
Read More
Curebase Launches Remote First DTx Research Platform
What You Should Know:
- Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics (DTx) trials that accelerates enrollment and allows sponsors to launch their studies faster.
- Available now, the new Curebase offering includes the first one-stop-shop decentralized clinical trial (DCT) platform bundled with site and trial execution services for the DTx market.
Making
Read More
Sharecare Launches VR Program to Bring Innovation to Exercise
What You Should Know:
- Digital health company Sharecare launches Get Active, a new virtual reality program to help employers encourage exercise among their workforces in a fun, approachable, and accessible way.
- In a pilot with its customer Lennar Corporation, one of the nation's leading homebuilders, Sharecare’s Get Active program for Meta Quest 2 yielded strong results for both healthy and high-risk Associates.
Lennar Pilot Program
In a pilot conducted in late 2022
Read More
